21 July 2021 - It’s not just politicians who are worried about the decision to approve a new Alzheimer’s drug.
Senators Bill Cassidy and Elizabeth Warren don’t agree on much. Yet both are troubled by the U.S. FDA’s approval of the Alzheimer’s disease drug Aduhelm.
In a recent letter, they took a slap at the drug, worrying that tens of billions of dollars would be spent on “just one product with limited evidence of clinical efficacy thus far.”